Metoclopramide for Nausea and Vomiting of Pregnancy: A Prospective Multicenter International Study

ABSTRACT

Nausea and vomiting are very common during pregnancy, mainly throughout the first trimester. Metoclopramide is a dopamine receptor blocking drug that is commonly used to treat nausea and vomiting. The aim of this prospective study was to investigate the effect on the fetus of intrauterine exposure to metoclopramide. One hundred and seventy-five women who received metoclopramide and consulted 6 teratogen information centers in Israel, Italy, Brazil, and Canada were studied. Women exposed to metoclopramide were paired for age, smoking and alcohol consumption habits with women exposed to nonteratogens. Women in the metoclopramide group had a significantly higher rate of premature births (8.1%) as compared with the control group (2.4%) (p = 0.02, relative risk = 3.37, 95% confidence interval 1.12-10.12). Rates of major malformations in the metoclopramide group (4.4%) did not differ from controls (4.8%) (p = 0.84, relative risk = 0.91, 95% confidence interval 0.34-2.45). According to our findings, metoclopramide use during the first trimester of pregnancy does not appear to be associated with an increased risk of malformations, spontaneous abortions, or decreased birth weight, however, larger studies are needed to confirm these observations.

KEYWORDS

Metoclopramide - nausea - vomiting - pregnancy

REFERENCES

• 1 Klebanoff M A, Mills J L. Is vomiting during pregnancy teratogenic?.  Br Med J . 1986;  292 724-726
• 2 Briggs J S. Vomiting in pregnancy: causes and management.  Drugs . 1975;  9 299-306
• 3 Walters W A, Humphrey M D. Common medical disorders and their treatment.  Drugs . 1980;  19 455-463
• 4 Drenth J P, Engles L G. Diabetic gastroparesis: a criterical reappraisal of new treatment strategies.  Drugs . 1992;  44 537-553
• 5 Cannon J G. Chemistry of dopaminergic agonists.  Adv Neurol . 1975;  9 177-183
• 6 Albibi R, McCallum R W. Metoclopramide: pharmacology and clinical application.  Ann Intern Med . 1983;  98 86-95
• 7 Eisner M. Effect of metoclopramide on gastrointestinal motility in man: a manometric study.  Dig Dis Sci . 1971;  16 409-419
• 8 Arvela P, Jouppila R, Kauppila A, Pakarina A, Pelkonen O, Tuimala R. Placental transfer and hormonal effects of metoclopramide.  Eur J Clin Pharmacol . 1983;  24 345-348
• 9 Bylsma-Howell M, Riggs K W, McMorland G H. Placental transport of metoclopramide: assessment of maternal and neonatal effects.  Can Anaesth Soc J . 1983;  30 487-492
• 10 Sorensen H T, Nielsen G L, Christensen K, Tage-Jensen U, Ekbom A, Baron J. Birth outcome following maternal use of metoclopramide.  Br J Clin Pharmacol . 2000;  49 264-268
• 11 Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy.  N Engl J Med . 2000;  343 445-446
• 12 Marden P M, Smith D W, McDonald M J. Congenital anomalies in the newborn infant, including minor variations.  J Pediatr . 1964;  64 357-371
• 13 Moore K L, Persand T VA. The Developing Human: Clinically Oriented Embryology.  Philadelphia: W.B. Saunders 1983
• 14 Koren G, Bologa M, Long D, Feldman Y, Shear N. Perception of teratogenic risk by pregnant women exposed to drug and chemicals during the first trimester.  Am J Obstet Gynecol . 1989;  160 1190-1194
• 15 Weigel R M, Weigel M M. Nausea and vomiting of early pregnancy and pregnancy outcome: a meta-analysis.  Br J Obstet Gynecol . 1989;  96 1312-1318
• 16 Van Stuijvenberg E M, Schabort I, Labadarios D, Nel T J. The nutritional status and treatment of patients with hyperemesis gravidarum.  Am J Obstet Gynecol . 1995;  172 1585-1591
• 17 Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects.  Br J Obstet Gynecol . 1995;  102 6-8
• 18 Newman C GH. Clinical aspects of thalidomide embryopathy: a continuing preoccupation.  Teratology . 1985;  32 133-144
• 19 Depue R H, Bernstein L, Ross R K, Judd H L, Henderson B E. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome and other maternal factors: a seroepidemiologic study.  Am J Obstet Gynecol . 1987;  157 1137-1141
• 20 Shulman A, Shapiro M S, Bahary G, Shenkman L. Abnormal thyroid function in hyperemesis gravidarum.  Acta Obstet Gynecol . 1989;  68 533-536
• 21 Koch K L, Stern R M, Vasey M, Botti J J, Creasy G W, Dwyer A. Gastric dysrhythmia and nausea of pregnancy.  Dig Dis Sci . 1998;  35 961-968
• 22 Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects.  Br J Obstet Gynecol . 1986;  5 187-196
• 23 Newman V, Fullerton J T, Anderson P O. Clinical advances in the management of severe nausea and vomiting during pregnancy.  J Obstet Gynecol Neonatal Nurs . 1993;  22 483-490
• 24 Shaw J, Brooks P M, McNeil J J, Moulds R FW, Revenscroft P J, Smith A J. The management of nausea and vomiting during pregnancy.  Med J Aust . 1987;  147 290-291
• 25 Einarson A, Koren G, Bergman V. Nausea and vomiting in pregnancy: a comparative European study.  Eur J Obstet Gynecol Reprod Biol . 1998;  76 1-3
• 26 Petridou E, Salvanos H, Skalkidou A, Dessypris N, Moustaki M, Trichopoulos D. Are there common triggers of preterm deliveries?.  Br J Obstet Gynaecol . 2001;  108 598-604
• 27 Schardein J L. Chemically Induced Birth Defects.  New York: Marcel Dekker 1985